par Metzger-Filho, Otto;de Azambuja, Evandro ;Bradbury, Ian;Saini, Kamal ;Bines, Jose;Simon, Sergio;van Dooren, Veerle;Aktan, Gursel;Pritchard, Kathleen;Wolff, Antonio C;Smith, Ian;Jackisch, Christian;Lang, Istvan;Untch, Michael;Boyle, Frances;Xu, Binghe;Baselga, José;Perez, Edith A;Piccart-Gebhart, Martine
Référence The oncologist, 18, 2, page (134-140)
Publication Publié, 2013
Référence The oncologist, 18, 2, page (134-140)
Publication Publié, 2013
Article révisé par les pairs
Titre: |
|
Auteur: | Metzger-Filho, Otto; de Azambuja, Evandro; Bradbury, Ian; Saini, Kamal; Bines, Jose; Simon, Sergio; van Dooren, Veerle; Aktan, Gursel; Pritchard, Kathleen; Wolff, Antonio C; Smith, Ian; Jackisch, Christian; Lang, Istvan; Untch, Michael; Boyle, Frances; Xu, Binghe; Baselga, José; Perez, Edith A; Piccart-Gebhart, Martine |
Informations sur la publication: | The oncologist, 18, 2, page (134-140) |
Statut de publication: | Publié, 2013 |
Sujet CREF: | Cancérologie |
Mots-clés: | Activation |
Ethics committee/institutional review board | |
Phase III clinical trials | |
MeSH keywords: | Antibodies, Monoclonal, Humanized -- administration & dosage -- therapeutic use |
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use | |
Breast Neoplasms -- drug therapy -- pathology | |
Clinical Trials, Phase III as Topic -- methods | |
Female | |
Humans | |
International Cooperation | |
Multicenter Studies as Topic -- methods | |
Quinazolines -- administration & dosage | |
Randomized Controlled Trials as Topic -- methods | |
Time Factors | |
Note générale: | SCOPUS: re.j |
Langue: | Anglais |
Identificateurs: | urn:issn:1083-7159 |
info:doi/10.1634/theoncologist.2012-0342 | |
info:pii/theoncologist.2012-0342 | |
info:scp/84874350918 | |
info:pmid/23359433 | |
PMC3579596 |